img

Global Biodefense Market Size By Product (Vaccines and Biothreat Detection Devices), By Application (Military, Civil), By End-User (Hospitals & Clinic, Ambulatory Care Centers), By Geographic Scope And Forecast


Published on: 2024-08-14 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Biodefense Market Size By Product (Vaccines and Biothreat Detection Devices), By Application (Military, Civil), By End-User (Hospitals & Clinic, Ambulatory Care Centers), By Geographic Scope And Forecast

Biodefense Market Size And Forecast

Biodefense Market size was valued at USD 15.6 Billion in 2021 and is projected to reach USD 32.48 Billion by 2030, growing at a CAGR of 8.49% from 2023 to 2030.

The growing number of naturally occurring outbreaks, the existence of encouraging government initiatives, the growing significance of disease surveillance missions to combat bioterrorism, the growing focus of public health services on the development of tests and procedures for the identification of biothreat agents, the growing threat of biological weapons and nuclear-armed ICBMs, and the growing awareness of the need for biodefense are the key factors that will propel the growth of the biodefense market near future. The report offers a detailed analysis of key segments, current trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Biodefense Market Definition

The intentionally release of viruses, bacteria, or other organisms to cause disease or death is known as a bioterrorism attack. These pathogens can frequently be discovered in the natural world. However, they can occasionally be rendered more hazardous by improving their capacity to spread, infect, or withstand medical intervention.

The spread of biological agents might occur through the water, food, or air. Some can pass from person to person as well. They might be very challenging to find. They don’t start making people sick for a few hours or days. Scientists are concerned that biological weapons could be made from anthrax, botulism, Ebola and other hemorrhagic fever viruses, plague, or smallpox. Medical safeguards are used in biodefense to protect against bioterrorism. This covers prescription drugs and vaccinations. Medical research and defences against bioterrorist threats are also included.

The comprehensive domestic security initiative of the US government includes biodefense as a crucial component. Its goal is to strengthen the country’s defences against bioterrorism, which is the intentional release of microbes or toxins from living things to cause illness or death in people, animals, or plants.

Global Biodefense Market Overview

The growing need for biodefense and the threat posed by dangerous biological agents that create emergencies are further factors driving the biodefense industry. For instance, due to the presence of well-established facilities for the creation of vaccines there, Asia-Pacific is one of the most developed regions for biodefense. Additionally, the country’s strong healthcare system contributes to its strong market position. Countries like China and India are aggressively increasing their R&D capabilities to prepare for upcoming biological threats. China spends the second-highest percentage of its GDP on R&D following the United States. The demand for biodefense is expected to rise as a result of these factors.

Because of recent scientific developments in the domains of genetic engineering and biotechnology, the deadly and naturally occurring viruses can now be easily manipulated to cause much more harm. Additionally, it is easy to obtain these organisms, making biodefense a crucial element for all countries in the world. Bioterrorists have previously used anthrax, botulism, as well as chemical and radioactive agents, as biological weapons to wreak significant economic damage. In order to protect against biological threats, reduce risks, and prepare for, respond to, and recover from bio-incidents, these events pushed the government to create biodefense laws, agreements, and regulations. Moreover, since the 2001 mail-borne anthrax bioterrorism attack, the National Institute of Infectious Disease has played a critical role in developing medical products and strategies to combat bioterrorism and emerging and re-emerging infectious diseases. It also conducts ongoing research to diagnose, treat, and prevent them, whether they are intentional or naturally occurring. However, over the  forecast period, the biodefense market may encounter new hurdles due to factors such as poor government financing for R&D activities in developing and undeveloped countries and severe regulatory requirements.

Furthermore,  number of governments have been collaborating with a number of international partners to aid response operations and enhance readiness. For instance, the experimental single-dose Ebola vaccine has received approval from both the World Health Organization and the DRC MoH for safe use. Approximately 250,000 individuals who are at risk of catching Ebola have received the vaccination as of November 17, 2019. Research on the Ebola and Zika viruses is being done by a large number of companies, notably Bavarian Nordic and Ology Bioservices, in countries with poor medical facilities and little research capability.

Global Biodefense Market Segmentation Analysis

The Global Biodefense Market is Segmented on the basis of Product, Application, End-User, And Geography.

Biodefense Market, By Product

  • Vaccines
    1. Anthrax
    2. Smallpox
    3. Botulism
    4. Others
  • Biothreat Detection Devices
    1. Samplers
    2. Detectors/Triggering Devices
    3. Identifiers
    4. Assays and Reagents
    5. Others

Based on the product, the market is bifurcated into Vaccines and Biothreat Detection Devices. Vaccines are expected to hold the lagest market share in the forecasted period owing to increased vaccine production worldwide. Researchers’ ongoing research into cutting-edge vaccine technologies, like vector technology, which induces fast protection against pathogen attacks, will further assist the growth of the biodefense sector. One oral dose of recently developed vaccinations can treat a wide range of bioterrorism chemicals and start a long-lasting immune response.

Biodefense Market, By Application

  • Military
  • Civil

Based on the application, the market is bifurcated into Military and Civil. Military expected to holds the largest market share by 2030. The segment is anticipated to experience considerable increase throughout the forecast period owing to growing demand from military sector

Biodefense Market, By End-User

  • Hospitals & Clinic
  • Ambulatory Care Centers
  • Others

Based on the End-User, the market is bifurcated into Hospitals & Clinic, Ambulatory Care Centers, and Others. The chemical segment expected to holds the largest market share by 2030. The hospitals and clinic segment is anticipated to experience considerable increase throughout the forecast period.

Biodefense Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Based on Regional Analysis, the Global Biodefense Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and the Latin America. The largest share in the market will be dominated by North America. The North American biodefense market, which accounted for largest worldwide revenue in 2021, is anticipated to rise rapidly over the next years as a result of the expanding significance of biodefense and the growing danger posed by harmful biological elements. Furthermore, the United States has one of the most advanced biodefense marketplaces in the region thanks to its well-established vaccine production facilities.

Key Players

The “Global Biodefense Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Alexeter Technologies, LLC., ClevlandBiolabs, Dynport Vaccine Company, Emergent Biosolutions, Altimmune Inc., XOMA Corporation, SIGA Technologies, Ichor Medical Systems, ology Bioservices, Bavarian Nordic, Alnylam Pharmaceuticals Inc., , Bruker Detection, Biosearch Technologies and  Other. 

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Biodefense Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Biodefense Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2018-2030

BASE YEAR

2021

FORECAST PERIOD

2023-2030

HISTORICAL PERIOD

2018-2020

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

Alexeter Technologies, LLC., ClevlandBiolabs, Dynport Vaccine Company, Emergent Biosolutions, Altimmune Inc., XOMA Corporation, SIGA Technologies, Ichor Medical Systems.

SEGMENTS COVERED

By Product, By Application, By End-User, And By Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )